Therapeutic Potential of Tumor Necrosis Factor-α and γ-Interferon in Experimental Human Ovarian Cancer

Cancer Research

Volumn 47, Issue 18, 1987, Pages 4755-4758

  Balkwill, Frances R ^a,b   Ward, I Bruce G ^a,b   Moodie, Elaine ^a,b   Fiers, Walter ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; DRUG ABUSE; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENTIATION; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; MOUSE; OVARY CANCER; THERAPY; TUMOR XENOGRAFT;

ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GLYCOPROTEINS; HUMAN; INTERFERON TYPE II; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR;

EID: 0023280093     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Toms, J. R., Draper, G. J., Stiller, C. A., Adelstein, A. M., Donnan, S. P. B., Fox, A. J., MacDonald-Davis, I. M., and White, G. C. Cancer statistics; incidence, survival and mortality in England and Wales. Studies on medical and population subjects, No. 43. London: HMSO.
2. Slevin, M. L. Ovarian cancer. In: M. L. Slevin and J. Staquet (eds.), Randomized Trials in Cancer A Critical Review by Sites, pp. 385–416. New York: Raven Press, 1986.
3. Einhorn, N., Cantell, K., Einhom, S., and Strander, H. Human leukocyte interferon for advanced ovarian carcinoma. Am. J. Clin. Oncol., 5; 167–172, 1982.
4. Abdullay, G., Disana, P. J., Blessing, J. A., and Creasman, W. T. Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynaecologic Oncology Group study. Am. J. Obst. Gynecol., 752:418-423,1985.
5. Niloff, J. M., Knapp, R. C., Jones, G., Schaetzl, E. M., and Bast, R. C. Recombinant leukocyte alpha interferon in advanced ovarian carcinoma. Cancer Treat Rep. 69:895-896,1985.
6. Berek, J. S., Hacker, N. F., Lichtenstein, A., Jung, T., Spina, C., Knox, R. M., Brady, J., Greene, T., Ettinger, L. M., Lagasse, L. D., Bonnem, E. M., Speigel, R. J., and Sigheboim, J. Intraperitoneal recombinant α-interferon for “salvage” immunotherapy in Stage III epithelial ovarian cancer Gynecologic Oncology Group study. Cancer Res., 45:4447-4453,1985.
7. Shepherd, J. H. Surgical management of ovarian cancer. In: J. H. Shepherd and J. M. Monaghan (eds.), Clinical Gynecological Oncology, pp. 187–207. Oxford, England: Blackwell Scientific Publications, 1985.
8. Ward, B. G., Wallace, K., Shepherd, J. H., and Balkwill, F. R. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res., 47: 2662–2667, 1987.
9. Balkwill, F. R., Goldstein, L., and Stebbing, N. Differential action of six human interferons against two human carcinomas growing in nude mice. int J. Cancer, 35:613-617,1985.
10. Fransen, L., Van der Heyden, J., Ruysschaert, R., and Fiers, W. Recombinant tumour necrosis factor its effect and its synergism with interferon-7 on a variety of normal and transformed human cell lines. Eur. J. Cancer Clin. Oncol., 22:419-426,1986.
11. Balkwill, F. R., Lee, A., Aldam, G., Moodie, E., Thomas, A., Tavernier, J., and Fiers, W. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res., 46:3990-3993,1986.
12. Balkwill, F. R., Aldam, G., and Lee, A. The action of interferons on human tumor xenografts in nude mice. In: F. Dianzani and G. B. Rossi (eds.), The Interferon System, Vol. 24, pp. 327–331. New York: Raven Press, 1986.
13. Balkwill, F. R., Fiers, W., and Ward, B. G. Anti-tumor effects of TNF on human tumor xenografts in nude mice. In: G. Bock and J. Marsh (eds.), Ciba Symposium No. 131 on Tumor Necrosis Factor and Related Cytokines, pp. 154–170. Chichester, England: John Wiley and Sons, 1987.
14. Brouckaert, P. G. G., Leroux-Roels, G. G., Guisez, Y., Tavernier, J., and Fiers, W. In vivo anti-tumor activity of recombinant human and murine TNF, alone and in combination with murine IFN-7, on a syngeneic murine melanoma. Int. J. Cancer, 38:763-769,1986.
15. Freireich, E. J., Gehan, R. A., Rail, D. A., Schmidt, L. H., and Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother. Rep., 50: 219–244, 1966.
16. Ortaldo, J. R., Porter, H. R., Miller, P., Stevenson, H. C., Ozols, R. F., and Hamilton, T. C. Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice. Cancer Res., 46:4414-4419,1986.